Understanding Sex Differences in Cancer Risk and Survival

Medically reviewed by | By

Update Date 30/12/2020 . 4 mins read
Share now

Though both men and women can develop cancer due to a variety of risk factors. There are some factors related to gender that affect both risk and outcome of treatment. What exactly are the gender or sex differences in cancer risk and survival?

To better understand this, it helps to look at they types of cancer common in both sexes.

In men, the most prevalent forms of cancer are prostate, colorectal, and lung cancers, which is estimated to be 43% of all cancers diagnosed in men.

Women on the other hand, more commonly develop lung, breast, and colorectal cancer, encompassing half of all new cancers diagnosed in women.

9 Cancer Screening Tests for Young Adults

The age standardized rate for all cancers globally as of 2018 is 197.9 per 100,000 people, this includes non-melanoma skin cancers (Squamous cell carcinomas and Basal cell carcinomas) and is a combined metric for both men and women.

However, men are more likely to develop cancer than women (218.6 per 100,000 men compared to 182.6 per 100,000 women). 

Sex Differences in Cancer Risk and Survival: Prevalence of cancer types

Previous data has shown that men are 20% more likely to develop cancer than women. They are also 40% more likely to die from cancer than women.

To understand why this is so, we must discuss the genetic/molecular differences between men and women.

Aside from cancer that affect sex-specific organs, sex differences can be seen in trends of other types of cancer.

This includes, but is not limited to:

  • Cancers with a higher incidence in women 
    • Thyroid
  • Cancers with a higher incidence in men
    • Colorectal
    • Stomach cancer
    • Liver cancer 
    • Bladder cancer 
    • Leukemia

sex differences in cancer risk and survival

How sex or gender influences cancer mortality

When it comes to sex differences in cancer risk and survival, it’s important to know that men are more likely to die due to cancer.

This is most evident when comparing the mortality rate of colorectal, lung, and stomach cancers between men and women.

However, it should be noted that women with cancers of the breast, uterus, and ovaries show a high mortality rate as well.

With the information available to us, the trends show that men are more likely to develop and subsequently die due to cancer.

This can be attributed to the lifestyle and behavior that is associated with most men.

Lung cancer, for example, is the leading cause of cancer death in men, mostly due to smoking.

Genetic/molecular differences in men and women

The genetic/molecular basis for the sex difference in the development and severity of cancers can be linked to genetic polymorphism.

This means genetic variation seen in different individuals.

Hormonal differences in men and women

Sex hormones also play a significant role in the development of cancer. As mentioned previously, high levels and long-term exposure of women to estrogen is a known risk factor in the development of breast cancer.

In contrast, estrogen exposure in men is limited. So their lower risk of developing breast cancer is evident in current statistics. Estrogen is also linked to a higher incidence of thyroid cancer among women.

Different Types of Hormonal Imbalances in Women

Reaction to therapy

In the treatment of cancer, chemotherapeutic drugs may be metabolized differently by men and women.

The clearance of some drugs may differ, causing a potentially dangerous drug to stay in the body for longer than other drugs. This may cause drug toxicity which causes adverse effects/ side effects.

For example, patients taking the chemotherapeutic drug 5-fluorouracil, a drug used in the treatment of colon, rectal, stomach, and pancreatic cancers, may causes adverse effects in women, such as stomatitis, leukopenia (decreased number of white blood cells), alopecia (balding), and diarrhea.

This is due to a poorer clearance of this drug, when taken by women compared to men. 

This trend is seen in several chemotherapeutic agents, such as your paclitaxel, cisplatin, doxorubicin, rituximab, and bevacizumab, which can complicate treatment due to the increased incidence of adverse effects in women. Although this plays a role in the outcome of patient treatment, it does not completely determine the outcome of cancer. 

In fact, early diagnosis of cancer is a more significant determinant of cancer outcomes, as this would permit treatment of cancer in its earlier stages, increasing the chance of curative therapy.

Some recent studies do state that immunotherapy in the treatment of cancer shows a sex-linked variance in its outcomes.

Men were noted to respond better to therapies that repress the immune system and that women respond more to immune therapies that stimulate immunity. However, evidence is limited and requires further investigation.

Key Takeaways

When it comes to sex differences in cancer risk and survival, there are multiple factors at work. These can be due to genetic or molecular variance through genetic polymorphism and the influence of estrogen in the development and protection from certain types of cancer.

Men are generally more susceptible to the development of cancer, however, some cancers such as thyroid cancer is more commonly seen in women. Therapy outcomes typically favor men, since women experience more adverse effects throughout the course of treatment.

New therapeutic regimens in the treatment of cancer, specifically immunotherapy show some variance in treatment for men and women. Proper screening and early diagnosis is still the best indicator of good outcomes for both men and women who are at risk.

Learn more about cancer causes and risk factors, here.

Hello Health Group does not provide medical advice, diagnosis or treatment.

Was this article helpful for you ?
happy unhappy
Sources

You might also like

What’s the Connection Between Obesity and Cancer?

What exactly is the connection between obesity and cancer? Can a person's unmanaged weight increase their chances of developing cancer? Find out here.

Medically reviewed by Dr. John Paul Abrina, M.D.
Written by Kip Soliva
Cancer Causes and Risk Factors 30/12/2020 . 4 mins read

9 Cancer Screening Tests for Young Adults

Early detection is truly the best form of cancer prevention. Learn all about the best cancer screening tests for young adults, here.

Medically reviewed by Dr. John Paul Abrina, M.D.
Written by Tracey Romero
Cancer Prevention 30/12/2020 . 4 mins read

Cancer Prevention: Why Screening Tests Are Important For Men

It’s a known fact that men are more susceptible to cancer more than women. This is why screening for cancer should be a priority especially for elderly adults who are male or at risk of certain types of cancer. Learn more about the recommended cancer screening tests for men, and the importance of screening for cancer even if you don’t experience any symptoms.

Medically reviewed by Dr. John Paul Abrina, M.D.
Written by Kip Soliva
Cancer Prevention 28/12/2020 . 4 mins read

Everything You Need to Know About Cancer Treatments

Aside from chemotherapy, what are the different types of cancer treatment? Learn more about them by reading this article.

Medically reviewed by Hello Doctor Medical Panel
Written by Kip Soliva
Cancer 20/12/2020 . 4 mins read

Recommended for you

Symptoms of Bladder Cancer

Symptoms of Bladder Cancer To Watch out for

Medically reviewed by Dr. John Paul Abrina, M.D.
Written by Kip Soliva
Published on 05/01/2021 . 4 mins read
obvious change in a wart or mole

Wart or mole changes: When is it a Sign of Skin Cancer?

Medically reviewed by Dr. John Paul Abrina, M.D.
Written by Tracey Romero
Published on 05/01/2021 . 5 mins read
stomach cancer stage 3 survival rate

Stomach Cancer Stage 3 Survival Rate: Prognosis and Treatment

Medically reviewed by Dr. John Paul Abrina, M.D.
Written by Den Alibudbud
Published on 04/01/2021 . 4 mins read
ways to prevent stomach cancer

11 Ways to Prevent Stomach Cancer

Medically reviewed by Dr. John Paul Abrina, M.D.
Written by Den Alibudbud
Published on 04/01/2021 . 4 mins read